1-8 of 8
Vinay Jain
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Crenolanib plus salvage chemotherapy improves outcomes in FLT3-mutant and NPM1 co-mutated relapsed/ refractory (R/R) Acute Myeloid Leukemia (AML): Results from a randomized, placebo-controlled, double-blind trial

Free
Thomas Cluzeau, Pierre Yves Dumas, Pau Montesinos, Gaia Ciolli, Céline Berthon, Felicetto Ferrara, Adriano Venditti, José Antonio Pérez-Simón, Maria Calbacho, Richard Noppeney, Monia Lunghi, Chiara Cattaneo, Fabrizio Pane, Francesco Lanza, Juan Miguel Bergua Burgues, Alessandro Isidori, Yngvar Floisand, Vinay Jain, Eunice Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 767.
https://doi.org/10.1182/blood-2025-767
Published: 2025
Journal Articles

Long-Term Follow-up of Crenolanib Maintenance after Allogeneic Transplantation in Newly Diagnosed and Relapsed FLT3 Mutated AML

Free
Betul Oran, David Marin, Qaiser Bashir, Sairah Ahmed, Amanda L. Olson, Uday Popat, Partow Kebriaei, Elizabeth J. Shpall, Vinay Jain, Richard E. Champlin
Journal: Blood
Blood (2024) 144 (Supplement 1): 1497.
https://doi.org/10.1182/blood-2024-207763
Published: 2024
Journal Articles

Low Relapse Rate in Younger Patients ≤ 60 Years Old with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) Treated with Crenolanib and Cytarabine/Anthracycline Chemotherapy

Free
Eunice S. Wang, MD, Martin S. Tallman, MD, Richard M. Stone, MD, Roland B. Walter, MD PhD, Chatchada Karanes, MD, Vinay Jain, MBBS, MD, Robert H. Collins, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 566.
https://doi.org/10.1182/blood.V130.Suppl_1.566.566
Published: 2017
Journal Articles

Anti-Tumor Activity of Low Dose Ocaratuzumab in Previously Treated Follicular Lymphoma Patients with Low-Affinity CD16 Polymorphisms

Free
Phuong H Le, MS, Andres Forero-Torres, MD, Nam H. Dang, MD, PhD, Mitchell R Smith, MD, PhD, Brian K Link, MD, Kristen N. Ganjoo, MD, Kensei Tobinai, MD, PhD, Minna Du, Adrienne O'Reilly, MS, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2012) 120 (21): 4884.
https://doi.org/10.1182/blood.V120.21.4884.4884
Published: 2012
Journal Articles

Pharmacokinetic and Pharmacodynamic Analysis of Ocaratuzumab in 50 Patients with Relapsed Follicular Lymphoma and Low-Affinity FcγRIIIa (CD16a) Polymorphisms.

Free
Minna Du, Adrienne O'Reilly, MS, Phuong H Le, MS, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2012) 120 (21): 2750.
https://doi.org/10.1182/blood.V120.21.2750.2750
Published: 2012
Journal Articles

Sustained Depletion of B-Cells by a Humanized, Fc-Engineered Anti-CD20 Antibody, AME-133v, in Patients with Relapsed Follicular Lymphoma

Free
Jennifer Wayne, MS, Kristen N. Ganjoo, MD, Andres Forero, MD, Brad Pohlman, MD, Sven de Vos, MD, PhD, Susan P. Carpenter, PhD, James E Wooldridge, MD, Shashidhara Marulappa, DVM, MVSc, MBA, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2011) 118 (21): 4977.
https://doi.org/10.1182/blood.V118.21.4977.4977
Published: 2011
Journal Articles

Impact of Physician to Physician Interactions Utilizing Case Based Learning Workshops to Accelerate Accrual to Lymphoma Trials.

Free
John Eckardt, MD, Nora Ku, MD, Annemieke DeMaggio, PhD, Omair Peracha, Nick Levonyak, Merrick H. Reese, MD, Mark Levonyak, Vinay Jain, MD, FACP
Journal: Blood
Blood (2009) 114 (22): 1418.
https://doi.org/10.1182/blood.V114.22.1418.1418
Published: 2009
Journal Articles

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

Free
Clinical Trials & Observations
Michael J. Keating, Ian Flinn, Vinay Jain, Jacques-Louis Binet, Peter Hillmen, John Byrd, Maher Albitar, Lee Brettman, Pedro Santabarbara, Bret Wacker, Kanti R. Rai
Journal: Blood
Blood (2002) 99 (10): 3554–3561.
https://doi.org/10.1182/blood.V99.10.3554
Published: 2002